Atria Wealth Solutions’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
DM
BG
Atria Wealth Solutions's AMED Position: Q4 2022 in Review
Atria Wealth Solutions sold out of Amedisys (AMED) in Q4 2022, closing a stake of 2,568 shares — an estimated $249K sold.
Atria Wealth Solutions first reported a position in AMED in Q1 2022 and held it in 3 quarters. The position peaked at $591K in Q2 2022. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.
- Atria Wealth Solutions reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
- Atria Wealth Solutions sold 2,568 Amedisys shares in Q4 2022, an estimated $249K.
- Atria Wealth Solutions first reported a position in Amedisys in Q1 2022 and held it in 3 quarters.
- Atria Wealth Solutions's Amedisys position peaked at $591K in Q2 2022.
- 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.
Based on Atria Wealth Solutions's 13F filing for Q4 2022, filed 13 Feb 2023.